Switch to:
More From Other Websites
Immunomedics Shares Slip Despite Encouraging Data on ADC Cancer Therapy Jan 22 2015
Seattle Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Year 2014... Jan 21 2015
Seattle Genetics to Host Conference Call and Webcast Discussion of Fourth Quarter and Year 2014... Jan 21 2015
Seattle Genetics and Bristol-Myers Squibb Announce Clinical Collaboration to Evaluate Combination of... Jan 15 2015
Eli Lilly Inks Oncology Deals with Merck, Bristol-Myers - Analyst Blog Jan 14 2015
Bristol-Myers' stock jumps on lung-cancer drug success Jan 12 2015
Seattle Genetics and Bristol-Myers Squibb Announce Clinical Collaboration to Evaluate Combination of... Jan 12 2015
Seattle Genetics and Bristol-Myers Squibb Announce Clinical Collaboration to Evaluate Combination of... Jan 12 2015
Seattle Genetics to Present at the J.P. Morgan Healthcare Conference Jan 06 2015
Juno Therapeutics hits $4B market cap as stock crests $50 a share Dec 29 2014
Seattle Genetics Initiates Phase 1b Trial of SGN-CD33A in Combination with Frontline Standard of... Dec 18 2014
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin)... Dec 08 2014
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS(R) (Brentuximab... Dec 08 2014
Seattle Genetics Presents Data from Novel Antibody-Drug Conjugate SGN-CD33A at ASH Annual Meeting Dec 08 2014
Seattle Genetics Presents ADCETRIS® (Brentuximab Vedotin) Data in Diffuse Large B-cell Lymphoma at... Dec 08 2014
Seattle Genetics Presents Data from Novel Antibody-Drug Conjugate SGN-CD33A at ASH Annual Meeting Dec 08 2014
Seattle Genetics Presents ADCETRIS® (Brentuximab Vedotin) Data in Diffuse Large B-cell Lymphoma at... Dec 08 2014
Seattle Genetics CEO: Blockbuster cancer drug? Dec 08 2014
Seattle Genetics-Takeda's Adcetris Shows Long-Term Effect Dec 08 2014
Seattle Genetics Highlights Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations in... Dec 08 2014
Seattle Genetics Highlights Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations in... Dec 08 2014
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab... Dec 08 2014
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin)... Dec 07 2014
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin)... Dec 07 2014
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin)... Dec 07 2014
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting Dec 06 2014
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting Dec 06 2014
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab... Dec 06 2014
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab... Dec 06 2014
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab... Dec 06 2014
Seattle Genetics Makes Case for Expanded Use of Adcetris as Lymphoma Maintenance Therapy Dec 06 2014
Biotech stocks to watch at ASH Dec 05 2014
Today's Water-Logged And Getting Wetter Stock: Seattle Genetics (SGEN) Nov 25 2014
Lixte Biotech: A Novel Approach to Boost Existing Cancer Therapies Nov 18 2014
Seattle Genetics Names New General Counsel and Executive Vice President, Legal Affairs Nov 18 2014
Seattle Genetics Names New General Counsel and Executive Vice President, Legal Affairs Nov 18 2014
Seattle Genetics to Present at Credit Suisse Healthcare Conference Nov 04 2014
Seattle Genetics Reports Third Quarter 2014 Financial Results Oct 30 2014
Seattle Genetics and Takeda Announce Positive Data from Phase 3 AETHERA Clinical Trial of ADCETRIS®... Sep 29 2014
Seattle Genetics Achieves Milestones Under Collaboration with Takeda for Achieving First Commercial... Apr 08 2014
Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Clinical Data at the 2014 Bone Marrow... Feb 27 2014
Seattle Genetics Reports Fourth Quarter and Year 2013 Financial Results Feb 12 2014
Seattle Genetics Announces Executive Promotions and Management Addition Feb 10 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK